You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BIOFRONTERA INC

Biofrontera Inc XNAS: BFRI

Biofrontera Inc Live Share Price Today, Share Analysis and Chart

Download real time

0.81 -0.04 (-4.71%)

66.67% Fall from 52W High

76,381 XNAS Volume

XNAS 28 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share

Biofrontera Inc Key Metrics

Default

Market Capitalization

Low in industry
7.2

PE TTM

Negative PE TTM
-0.4

Price to Book

Below industry Median
1.3

Institutional holding current Qtr %

Below industry Median
21.6

Revenue Growth Qtr YoY %

Below industry Median
18.5

Operating Revenue growth TTM %

Below industry Median
9.5

Net Profit Qtr Growth YoY %

Negative Net Profit Qtr Growth YoY %
-139.6

Net Profit TTM Growth %

Below industry Median
11.8

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-44.4

Piotroski Score

High in industry
3

Rel Perf vs Sector quarter%

-29.1
All financials are in USD Million and price data in USD
VIEW MORE

6

S

11

W

1

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Biofrontera Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '262030405060Actual RevenueAvg. Estimate
Miss

Biofrontera Inc's Revenue was lower than average estimate 3 times in past 3 years

EPS forecast

Current EPS
-3.2
Avg. Estimate
-0.8
Low Estimate
-1.1
High Estimate
-0.5
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 76.1% in FY25

Consensus Recommendation

2 ANALYST Recommendations
BUY

Created with Highcharts 7.2.21Buy1Strong Buy

The consensus recommendation from 2 analysts for Biofrontera Inc is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Biofrontera Inc Stock Analysis

Biofrontera Inc stock analysis with key metrics, changes, and trends.

Biofrontera Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$37.32 M9.54%positive

Annual Revenue rose 9.54%, in the last year to $37.32 M. Its sector's average revenue growth for the last fiscal year was 7.47%.

Annual Net Profit$17.76 M11.78%positive

Annual Net Profit rose 11.78% in the last year to $17.76 M. Its sector's average net profit growth for the last fiscal year was -32.42%.

Price to Earning Ratio-0.4-negative

Price to Earning Ratio is -0.4, which is negative.

Stock Price$0.81-47.4%negative

Stock Price fell 47.4% and underperformed its sector by 53.07% in the past year.

Quarterly Revenue$12.56 M18.53%positive

Quarterly Revenue rose 18.53% YoY to $12.56 M. Its sector's average revenue growth YoY for the quarter was 5.96%.

Quarterly Net profit$1.4 M139.59%negative

Quarterly Net profit fell 139.59% YoY to $1.4 M. Its sector's average net profit growth YoY for the quarter was -47.39%.

Mutual Fund Holding1.52 %-0.05%negative

Mutual Fund Holding decreased by 0.05% in the last quarter to 1.52.

Institutional Holding21.60 %7.49%positive

Institutional Holding increased by 7.49% in the last quarter to 21.6.

VIEW LESS


Loading data..

Biofrontera Inc - Company Profile

What does Biofrontera Inc do?

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Biofrontera Inc Management structure

All Gross Remunerations are in USD
Dr. Hermann Luebbert, PhD
Executive Chairman of the Board and Chief Executive Officer
733.23 K
2023
Gross Remuneration
Year
Ms. Erica Monaco, C.P.A.
Chief Executive Officer
702.22 K
2023
Gross Remuneration
Year
Mr. Eugene Fredrick Leffler, III
Chief Financial Officer and Principal Accounting Officer
441.68 K
2023
Gross Remuneration
Year

Biofrontera Inc FAQ

How is Biofrontera Inc today?
Biofrontera Inc today is trading in the red, and is down by -4.71% at 0.81.
Biofrontera Inc is currently trading down -4.71% on an intraday basis. In the past week the stock fell -5.81%. stock has been down -24.30% in the past quarter and fell -47.40% in the past year. You can view this in the overview section.